|
| related topics |
| {stock, price, share} |
| {stock, price, operating} |
| {product, market, service} |
| {acquisition, growth, future} |
| {personnel, key, retain} |
| {regulation, government, change} |
| {control, financial, internal} |
| {tax, income, asset} |
|
|
If the Company s competitors are successful in developing, manufacturing and selling competitive products, the Company s operating results could suffer.
If the Company is unable, for technical, legal, financial or other reasons, to adapt in a timely manner in response to changing market conditions or customer requirements, the Company s business, prospects, financial condition and results of operations would be materially adversely affected.
The Company is dependent upon the levels of student enrollment in elementary and secondary schools and expenditures per student.
If the Company fails to retain key personnel and hire, train and retain qualified employees, the Company may not be able to compete effectively, which could result in reduced sales.
The Company expects its results of operations to fluctuate from quarter to quarter, and the price of its Common Stock and Series I Preferred Stock could fall if quarterly results are lower than the expectations of the market.
The Company s stock price may fluctuate based on factors beyond its control.
Geneve beneficially owns more than 90% of the aggregate voting power of the Company.
Concentration of common share ownership and limited number of shares outstanding could prevent an active market for the Company s Common Stock and Series I Preferred Stock.
Geneve owns 100% of the Company s Series J Preferred Stock.
The Company may not pay dividends on the Series I Preferred Stock.
Conversion of the Series I Preferred Stock into Common Stock may not compensate for non-payment of dividends or lack of liquidity.
Certain factors may affect the Company s ability to fully utilize its NOLs.
The Company may not be able to obtain financing and additional capital to fund its business strategy on acceptable terms.
The Company may expand its business through acquisitions.
The Company may be required to expend significant resources to comply with Section 404 of the Sarbanes-Oxley Act and may not be able to comply on a timely basis, if at all.
Full 10-K form ▸
|
|
| related documents |
| 790071--3/24/2006--ARISTOTLE_CORP |
| 790071--3/27/2008--ARISTOTLE_CORP |
| 790071--3/26/2009--ARISTOTLE_CORP |
| 1331520--3/20/2007--HOME_BANCSHARES_INC |
| 1292026--3/31/2008--Odimo_INC |
| 1099132--4/9/2010--MANHATTAN_SCIENTIFICS_INC |
| 850414--6/25/2007--NEW_HORIZONS_WORLDWIDE_INC |
| 1419260--1/6/2010--Andina_Group_Inc. |
| 1109525--3/9/2006--BANCORP_RHODE_ISLAND_INC |
| 81350--4/16/2009--BLINK_LOGIC_INC. |
| 1398797--9/19/2008--Point.360 |
| 1083243--3/4/2009--ZAP_COM_CORP |
| 919567--3/27/2008--RENAISSANCE_CAPITAL_GROWTH_&_INCOME_FUND_III_INC |
| 1366823--3/27/2009--SPRING_CREEK_CAPITAL_CORP. |
| 351017--3/27/2008--AUTOINFO_INC |
| 1083243--3/7/2008--ZAP_COM_CORP |
| 351017--3/23/2009--AUTOINFO_INC |
| 779956--4/30/2007--FASTFUNDS_FINANCIAL_CORP |
| 919567--9/22/2006--RENAISSANCE_CAPITAL_GROWTH_&_INCOME_FUND_III_INC |
| 75439--3/31/2009--CytoCore_Inc |
| 850414--3/28/2008--NEW_HORIZONS_WORLDWIDE_INC |
| 1080627--7/9/2008--GOLDEN_KEY_INTERNATIONAL_INC |
| 822418--3/5/2008--BIO_IMAGING_TECHNOLOGIES_INC |
| 1083243--3/14/2006--ZAP_COM_CORP |
| 1256540--8/13/2009--EAST_COAST_DIVERSIFIED_CORP |
| 1089473--3/16/2006--VENTIV_HEALTH_INC |
| 893816--3/15/2006--INFOCROSSING_INC |
| 1419260--9/2/2010--Andina_Group_Inc. |
| 893816--3/16/2007--INFOCROSSING_INC |
| 1089473--2/28/2007--INVENTIV_HEALTH_INC |
|